KMPH - KemPharm EPS beats by $0.02 misses on revenue November, 10 2021 04:10 PM KemPharm Inc KemPharm (NASDAQ:KMPH): Q3 GAAP EPS of -$0.06 beats by $0.02. Revenue of $1.97M (+3.7% Y/Y) misses by $0.18M. Press Release For further details see: KemPharm EPS beats by $0.02, misses on revenue